Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Genetic testing may help patients with metastatic breast cancer

Breast cancer is a condition wherein the cells in the breast grow uncontrollably. Breast cancer can spread to the other parts of the body, termed as metastatic breast cancer. It is one of the most aggressive and potentially deadly types of cancer.

10 Sep 2019

Study shows safety, efficacy of fertility-sparing surgery for treatment of early-stage ovarian cancer

Young women with early stage ovarian cancer can undergo fertility-preserving surgery without affecting the safety of their cancer treatment, researchers from Karolinska Institutet in Sweden report in a national study published in the journal Gynecologic Oncology.

4 Sep 2019

Study links FAK protein to chemotherapy resistance in ovarian cancer

Although the number of women being diagnosed and dying of ovarian cancer is declining, recurrence, drug resistance and mortality remain high for women with high-grade serous ovarian carcinoma, the most common form of epithelial ovarian cancer.

3 Sep 2019

New test could enable early detection of ovarian cancer

Researchers from Queen's University Belfast have developed a test that may be able to detect ovarian cancer up to two years earlier than current approaches.

23 Aug 2019

New therapy found to be effective for patients with a particular type of bone marrow cancer

Mount Sinai researchers have found a new type of therapy to be effective for patients with a particular type of bone marrow cancer that is resistant to several standard therapies, according to results of a clinical trial published in The New England Journal of Medicine in August.

22 Aug 2019

Cancer survivors could be at greater risk of cardiovascular diseases

Over the last few decades, medical progress has led to the survival of many more people with cancer. However, a new study published in The Lancet shows that this cohort has a higher risk of cardiovascular disease (CVD) than controls without cancer, due to a number of reasons.

21 Aug 2019

New Recommendation Statement for BRCA1/2 evaluation still fails to address many problems

The U.S. Preventive Services Task Force has released a new Recommendation Statement for BRCA1/2 evaluation, urging the medical community to widen the parameters used to assess BRCA1 and BRCA2 mutation risks and increase the use of genetic counseling and testing for those with the highest risk.

21 Aug 2019

Protein governing platinum-resistant ovarian cancer identified

The extracellular regulated kinase (ERK) protein is an important mechanism behind platinum-resistance in platinum-resistant ovarian cancer, according to a study from a research team at the George Washington University (GW) Cancer Center.

18 Aug 2019

Targeted pancreatic cancer drug shows promise in clinical trials

Researchers have conducted clinical trials with a new drug targeting pancreatic cancer and the initial results are promising.

16 Aug 2019

New drug to treat pancreatic cancer shows promising results in clinical trial

A clinical trial testing a new drug in pancreatic cancer had promising initial results, report researchers from the University of Michigan Rogel Cancer Center.

14 Aug 2019

Roswell Park receives more than $15 million in grants for cancer research

Roswell Park Comprehensive Cancer Center researchers have received more than a dozen recent grant awards totaling more than $15.4 million.

14 Aug 2019

Management of ovarian cancer risk in women with BRCA1/2 gene mutations

A new review to help physicians manage the risk of ovarian cancer in women who carry the BRCA1/2 gene mutations is published in CMAJ.

12 Aug 2019

Researchers identify gene mutation combo linked to endometrial cancer

Michigan State University researchers, in collaboration with the Van Andel Institute, have identified a combination of two gene mutations that is linked to endometrial cancer.

7 Aug 2019

New device traps and analyzes single cells for faster HPV-related cervical cancer screening

Several screening tests for cervical cancer have been developed in recent years. One technique uses immunofluorescent staining to determine the levels of biomarkers to indicate a cell is undergoing HPV-related cancerous growth.

31 Jul 2019

Research links inherited BRCA2 mutations with increased risk of childhood lymphoma

A report from St. Jude Children's Research Hospital links inherited mutations in the BRCA2 gene with an increased risk of developing non-Hodgkin lymphoma in children and adolescents.

25 Jul 2019

Women who inherit BRCA mutations have high risk of developing cancer

Women who inherit harmful mutations in the BRCA1 or BRCA2 gene are at high risk of developing breast and ovarian cancer.

24 Jul 2019

People with cancer have trouble accessing appropriate psychological support

People with cancer have trouble accessing appropriate psychological support, a new global report published today by the All.Can international cancer initiative reveals.

24 Jul 2019

All.Can report urges health officials, decision-makers to 'do the right thing by patients'

The international All.Can cancer initiative has today published a major report urging health officials, governments and decision-makers to 'do the right thing by patients' when developing cancer care plans and policies by taking patient insights into account in all aspects of treatment and care.

24 Jul 2019

Combining breast and gynecologic surgery not such a good idea

A new study from the University of Colorado Cancer Center finds that it is best if women who have to have both preventive gynecologic and breast surgeries have them done separately. The same dictum applies to breast reconstructive procedures following a mastectomy.

16 Jul 2019

New protein target for deadly ovarian cancer

A new study shows that targeting a specific protein found within quickly spreading high-grade serous carcinomas (HGSC) of the ovary could help contain these cancers. HGSC is the most common and deadly form of epithelial ovarian cancer, which is itself the deadliest cancer of the female reproductive tract.

14 Jul 2019

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Genetic testing may help patients with metastatic breast cancer

Study shows safety, efficacy of fertility-sparing surgery for treatment of early-stage ovarian cancer

Study links FAK protein to chemotherapy resistance in ovarian cancer

New test could enable early detection of ovarian cancer

New therapy found to be effective for patients with a particular type of bone marrow cancer

Cancer survivors could be at greater risk of cardiovascular diseases

New Recommendation Statement for BRCA1/2 evaluation still fails to address many problems

Protein governing platinum-resistant ovarian cancer identified

Targeted pancreatic cancer drug shows promise in clinical trials

New drug to treat pancreatic cancer shows promising results in clinical trial

Roswell Park receives more than $15 million in grants for cancer research

Management of ovarian cancer risk in women with BRCA1/2 gene mutations

Researchers identify gene mutation combo linked to endometrial cancer

New device traps and analyzes single cells for faster HPV-related cervical cancer screening

Research links inherited BRCA2 mutations with increased risk of childhood lymphoma

Women who inherit BRCA mutations have high risk of developing cancer

People with cancer have trouble accessing appropriate psychological support

All.Can report urges health officials, decision-makers to 'do the right thing by patients'

Combining breast and gynecologic surgery not such a good idea

New protein target for deadly ovarian cancer

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in